Hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B: The multicentre, prospective CAP‐Asia study

Baveno VII – Renewing consensus in portal hypertension

(2021) Roberto de Franchis et al.   JOURNAL OF HEPATOLOGY

Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B

(2020) Lung-Yi Mak et al.   JOURNAL OF HEPATOLOGY

Fatty liver is associated with advanced fibrosis but does not predict adverse outcomes in patients with chronic hepatitis B

(2020) Sui‐Weng Wong et al.   JOURNAL OF VIRAL HEPATITIS

Unhealthy lifestyle habits and physical inactivity among Asian patients with non‐alcoholic fatty liver disease

(2020) Xinrong Zhang et al.   LIVER INTERNATIONAL

NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment

(2020) Giovanni Targher et al.   DIABETES & METABOLISM

6. Glycemic Targets: Standards of Medical Care in Diabetes—2021

(2020)   DIABETES CARE

2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021

(2020)   DIABETES CARE

Chronic hepatitis B and metabolic risk factors: A call for rigorous longitudinal studies

(2019) Wai-Kay Seto   WORLD JOURNAL OF GASTROENTEROLOGY

Non‐Alcoholic steatohepatitis is associated with liver‐related outcomes and all‐cause mortality in chronic hepatitis B

(2019) Hannah S. J. Choi et al.   HEPATOLOGY

Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease

(2019) Stanley Khoo et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis

(2019) Jie Li et al.   Lancet Gastroenterology & Hepatology

Association Between Hepatic Steatosis, Measured by Controlled Attenuation Parameter, and Fibrosis Burden in Chronic Hepatitis B

(2018) Wai-Kay Seto et al.   Clinical Gastroenterology and Hepatology

Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?

(2018) Amedeo Lonardo et al.   JOURNAL OF HEPATOLOGY

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults

(2018) Paul K. Whelton et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Summary of Revisions: Standards of Medical Care in Diabetes—2019

(2018)   DIABETES CARE

Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B

(2017) Anthony W H Chan et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment

(2017) Vincent Wai-Sun Wong et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

(2017) Thomas Karlas et al.   JOURNAL OF HEPATOLOGY

Inverse relationship between hepatic steatosis and hepatitis B viremia: Results of a large case-control study

(2017) R. W. H. Hui et al.   JOURNAL OF VIRAL HEPATITIS

The impact of chronic hepatitis B infection on major adverse cardiovascular events and all-cause mortality in patients with diabetes: a nationwide population-based study from Taiwan

(2017) Chin-Sung Kuo et al.   BMJ Open

Metabolic syndrome increases cardiovascular events but not hepatic events and death in patients with chronic hepatitis B

(2016) Jenny Yeuk-Ki Cheng et al.   HEPATOLOGY

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease

(2016)   Obesity Facts

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

(2015) Paul Angulo et al.   GASTROENTEROLOGY

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

(2015) Mattias Ekstedt et al.   HEPATOLOGY

Expanding consensus in portal hypertension

(2015) Roberto de Franchis   JOURNAL OF HEPATOLOGY

Determination of reliability criteria for liver stiffness evaluation by transient elastography

(2012) Jérôme Boursier et al.   HEPATOLOGY

HEPATIC STEATOSIS IN HEPATITIS B VIRUS INFECTED PATIENTS - META-ANALYSIS OF RISK FACTORS AND COMPARISON WITH HEPATITIS C INFECTED PATIENTS

(2011) Mariana V. Machado et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Hepatitis B virus infection and fatty liver in the general population

(2011) Vincent Wai-Sun Wong et al.   JOURNAL OF HEPATOLOGY

Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

(2010) Giovanni Musso et al.   ANNALS OF MEDICINE

Final results of a long-term, clinical follow-up in fatty liver patients

(2009) Sanne Dam-Larsen et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

General Cardiovascular Risk Profile for Use in Primary Care

(2008) Ralph B. D’Agostino et al.   CIRCULATION